Integrating Exposure and Response Prevention With a Mobile App to Treat Obsessive-Compulsive Disorder: Feasibility, Acceptability, and Preliminary Effects

被引:11
|
作者
Gershkovich, Marina [1 ,2 ]
Middleton, Rachel [1 ,2 ]
Hezel, Dianne M. [1 ,2 ]
Grimaldi, Stephanie [3 ]
Renna, Megan [4 ]
Basaraba, Cale [1 ]
Patel, Sapana [1 ,2 ]
Simpson, H. Blair [1 ,2 ]
机构
[1] New York State Psychiat Inst & Hosp, 1051 Riverside Dr, New York, NY 10025 USA
[2] Columbia Univ, Med Ctr, New York, NY 10027 USA
[3] Hofstra Univ, Hempstead, NY 11550 USA
[4] Ohio State Univ, Coll Med, Columbus, OH 43210 USA
关键词
cognitive-behavioral therapy; treatment; OCD; mobile app; technology; COGNITIVE-BEHAVIORAL THERAPY; CONTROLLED-TRIAL; SELF-HELP; METAANALYSIS; SCALE; INTERVENTIONS; REMISSION; ANXIETY;
D O I
10.1016/j.beth.2020.05.001
中图分类号
B849 [应用心理学];
学科分类号
040203 ;
摘要
Many individuals with obsessive-compulsive disorder (OCD) do not receive evidence-based care (specifically exposure and ritual prevention; EX/RP) due to barriers such as a lack of EX/RP-trained clinicians, geographic obstacles, and the cost and time associated with the treatment. Offering an integrated treatment model consisting of brief in-person therapy coupled with a mobile application (app) might be one way to increase access to and reduce the time burden (to clinicians and patients) of EX/RP. This pilot trial evaluated the feasibility, acceptability, and clinical effects of such a treatment program for adults with OCD. Thirty-three participants enrolled in the 8-week open trial. The integrated treatment program consisted of 3 to 5 in-person sessions followed by weekly phone calls supported by a mobile app (nOCD). Participants were evaluated by trained raters and completed self-report measures at baseline, midtreatment, posttreatment and 2-month follow-up; the Yale-Brown Obsessive-Compulsive Scale (Y-BOCS) was the primary outcome. This integrated treatment program was feasible and acceptable to participants. Of the 33 study entrants, 14 (42%) responded to treatment (Y-BOCS decrease >= 35% with CGI- of 1 or 2), and 8 (24%) achieved minimal symptoms (i.e., Y-BOCS <= 12). At 2-month follow-up (n=20), 7/20 (35%) met criteria for treatment response, and 3/20 (15.0%) met criteria for treatment remission. Although preliminary, this model warrants further study as an efficacious and resource-efficient way to deliver EX/RP for some patients with OCD.
引用
收藏
页码:394 / 405
页数:12
相关论文
共 50 条
  • [31] Acceptability, feasibility, and efficacy of Internet cognitive behavioral therapy (iCBT) for pediatric obsessive-compulsive disorder: a systematic review
    Babiano-Espinosa, Lucia
    Wolters, Lidewij H.
    Weidle, Bernhard
    de Beek, Vivian Op
    Pedersen, Sindre A.
    Compton, Scott
    Skokauskas, Norbert
    SYSTEMATIC REVIEWS, 2019, 8 (01)
  • [32] Adding acceptance and commitment therapy to exposure and response prevention for obsessive-compulsive disorder: A randomized controlled trial
    Twohig, Michael P.
    Abramowitz, Jonathan S.
    Smith, Brooke M.
    Fabricant, Laura E.
    Jacoby, Ryan J.
    Morrison, Kate L.
    Bluett, Ellen J.
    Reuman, Lillian
    Blakey, Shannon M.
    Ledermann, Thomas
    BEHAVIOUR RESEARCH AND THERAPY, 2018, 108 : 1 - 9
  • [33] Homework Completion in Treating Obsessive-Compulsive Disorder with Exposure and Ritual Prevention: A Review of the Empirical Literature
    Wheaton, Michael G.
    Chen, Stephanie R.
    COGNITIVE THERAPY AND RESEARCH, 2021, 45 (02) : 236 - 249
  • [34] Preliminary Predictors of Within-Session Adherence to Exposure and Response Prevention in Pediatric Obsessive-Compulsive Disorder
    Morgan, Jessica
    Caporino, Nicole E.
    De Nadai, Alessandro S.
    Truax, Tatyana
    Lewin, Adam B.
    Jung, Leah
    Park, Jennifer M.
    Khan, Yasmeen Ali
    Murphy, Tanya K.
    Storch, Eric A.
    CHILD & YOUTH CARE FORUM, 2013, 42 (03) : 181 - 191
  • [35] Metacognitive therapy versus exposure and response prevention for obsessive-compulsive disorder - A non-inferiority randomized controlled trial
    Exner, Cornelia
    Kleiman, Alexandra
    Haberkamp, Anke
    Hansmeier, Jana
    Milde, Christopher
    Glombiewski, Julia Anna
    JOURNAL OF ANXIETY DISORDERS, 2024, 104
  • [36] Cognitive Mediation of Symptom Change in Exposure and Response Prevention for Obsessive-Compulsive Disorder
    Su, Yi-Jen
    Carpenter, Joseph K.
    Zandberg, Laurie J.
    Simpson, Helen Blair
    Foa, Edna B.
    BEHAVIOR THERAPY, 2016, 47 (04) : 474 - 486
  • [37] A Preliminary Examination of Acceptance and Commitment Therapy Versus Exposure and Response Prevention for Patients with Obsessive-Compulsive Disorder on an Optimal Dose of SSRIs: A Randomized Controlled Trial in Iran
    Zemestani, Mehdi
    Salavati, Mojgan
    Seyedolshohadayi, Asrin
    Petersen, Julie M.
    Ong, Clarissa W.
    Twohig, Michael P.
    Ghaderi, Ebrahim
    BEHAVIOR MODIFICATION, 2022, 46 (03) : 553 - 580
  • [38] Effectiveness of Video Teletherapy in Treating Obsessive-Compulsive Disorder in Children and Adolescents With Exposure and Response Prevention: Retrospective Longitudinal Observational Study
    Feusner, Jamie D.
    Farrell, Nicholas R.
    Nunez, Mia
    Lume, Nicholas
    Macdonald, Catherine W.
    Mcgrath, Patrick B.
    Trusky, Larry
    Smith, Stephen
    Rhode, Andreas
    JOURNAL OF MEDICAL INTERNET RESEARCH, 2025, 27
  • [39] Task-based fMRI predicts response and remission to exposure therapy in obsessive-compulsive disorder
    Pagliaccio, David
    Middleton, Rachel
    Hezel, Dianne
    Steinman, Shari
    Snorrason, Ivar
    Gershkovich, Marina
    Campeas, Raphael
    Pinto, Anthony
    Van Meter, Page
    Simpson, H. Blair
    Marsh, Rachel
    PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2019, 116 (41) : 20346 - 20353
  • [40] An Avoidance-Based Rodent Model of Exposure With Response Prevention Therapy for Obsessive-Compulsive Disorder
    Rodriguez-Romaguera, Jose
    Greenberg, Benjamin D.
    Rasmussen, Steven A.
    Quirk, Gregory J.
    BIOLOGICAL PSYCHIATRY, 2016, 80 (07) : 534 - 540